Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide

N Darwiche, G Abou-Lteif, T Najdi… - Biochemical …, 2005 - portlandpress.com
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …
被引用次数：11 相关文章
[PDF] academia.edu

[PDF][PDF] Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N DARWICHE, G ABOU-LTEIF, T NAJDI, L KOZHAYA… - Biochem. J, 2005 - academia.edu
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …

Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide.

N Darwiche, G Abou-Lteif, T Najdi… - The Biochemical …, 2005 - europepmc.org
Abstract Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes
growth arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and …

Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N Darwiche, G Abou-Lteif, T Najdi… - The Biochemical …, 2005 - pubmed.ncbi.nlm.nih.gov
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …
[PDF] researchgate.net

[PDF][PDF] Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N DARWICHE, G ABOU-LTEIF, T NAJDI… - Biochem. J, 2005 - researchgate.net
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …
[HTML] nih.gov

[HTML][HTML] Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N Darwiche, G Abou-Lteif, T Najdi, L Kozhaya… - Biochemical …, 2005 - ncbi.nlm.nih.gov
Abstract Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes
growth arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and …
[PDF] psu.edu

[PDF][PDF] Human T-Cell Lymphotropic Virus Type I-Transformed T Cells Have a Partial Defect in Ceramide Synthesis in Response to N-(4-Hydroxyphenyl) Retinamide

N Darwiche, G Abou-Lteif, T Najdi, L Kozhaya, A Abou - 2005 - Citeseer
Treatment with the synthetic retinoid N-(4-hydroxyphenyl) retinamide (HPR) 1 causes growth
arrest and apoptosis in human T-cell lymphotropic virus type I (HTLV-I) positive and HTLV-I …
[PDF] researchgate.net

[PDF][PDF] Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N DARWICHE, G ABOU-LTEIF, T NAJDI… - Biochem. J, 2005 - researchgate.net
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …

Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide.

N Darwiche, G Abou-Lteif, T Najdi… - The Biochemical …, 2005 - europepmc.org
Abstract Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes
growth arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and …
[PDF] academia.edu

[PDF][PDF] Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl) retinamide

N DARWICHE, G ABOU-LTEIF, T NAJDI, L KOZHAYA… - Biochem. J, 2005 - academia.edu
Treatment with the synthetic retinoid HPR [N-(4-hydroxyphenyl)-retinamide] causes growth
arrest and apoptosis in HTLV-I (human T-cell lymphotropic virus type-I)-positive and HTLV-I …